{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:38:20Z","timestamp":1790735900525,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002607","name":"American Speech-Language-Hearing Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.heares.2019.107878","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T08:58:56Z","timestamp":1577782736000},"page":"107878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Cisplatin-induced threshold shift in the CBA\/CaJ, C57BL\/6J, BALB\/cJ mouse models of hearing loss"],"prefix":"10.1016","volume":"387","author":[{"given":"J. Riley","family":"DeBacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Bielefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heares.2019.107878_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1026454831340","article-title":"ESHAP is an active regimen for relapsing Hodgkin\u2019s disease","volume":"10","author":"Aparicio","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.heares.2019.107878_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.heares.2019.107878_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.heares.2018.09.004","article-title":"Chronotolerance for cisplatin ototoxicity in the rat","volume":"370","author":"Bielefeld","year":"2018","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CAD.0b013e32835739fd","article-title":"An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect","volume":"24","author":"Bielefeld","year":"2013","journal-title":"Anti Canccer Drugs"},{"key":"10.1016\/j.heares.2019.107878_bib5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heares.2019.107878_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00464398","article-title":"Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology","volume":"242","author":"B\u00f6heim","year":"1985","journal-title":"Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.heares.2019.107878_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-0749.1993.tb00612.x","article-title":"Role of melanin as a scavenger of active oxygen species","volume":"6","author":"Bustamante","year":"1993","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.heares.2019.107878_bib8","first-page":"169","article-title":"Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity","volume":"67","author":"Campbell","year":"1983","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.heares.2019.107878_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-5955(00)00059-9","article-title":"Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino Guinea pig cochlea","volume":"144","author":"Cardinaal","year":"2000","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib10","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.2147\/IJN.S195336","article-title":"Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity","volume":"14","author":"Chen","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.heares.2019.107878_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0378-5955(96)00075-5","article-title":"Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants","volume":"98","author":"Clerici","year":"1996","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5955(89)90177-9","article-title":"Differential susceptibility to gentamicin ototoxicity between albino and pigmented Guinea pig","volume":"41","author":"Conlee","year":"1989","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002820-199408000-00001","article-title":"Cisplatin: a clinical review. Part I--Current uses of cisplatin and administration guidelines","volume":"17","author":"Cooley","year":"1994","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.heares.2019.107878_bib14","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2004.08.015","volume":"22","author":"Cushing","year":"2004","journal-title":"J.\u00a0Clin. Orthod."},{"key":"10.1016\/j.heares.2019.107878_bib15","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2001.19.17.3733","article-title":"Body-surface area\u2013based dosing does not increase accuracy of predicting cisplatin exposure","volume":"19","author":"de Jongh","year":"2001","journal-title":"J.\u00a0Clin. Orthod."},{"key":"10.1016\/j.heares.2019.107878_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/AUD.0000000000000391","article-title":"Long-term synergistic interaction of cisplatin-induced and noise-induced hearing losses","volume":"38","author":"DeBacker","year":"2017","journal-title":"Ear Hear."},{"key":"10.1016\/j.heares.2019.107878_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/taap.2001.9171","article-title":"Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals","volume":"174","author":"Dehne","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.heares.2019.107878_bib18","article-title":"Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy","volume":"25434","author":"Driessen","year":"2019","journal-title":"Head Neck hed"},{"key":"10.1016\/j.heares.2019.107878_bib19","first-page":"87","article-title":"A\u00a0role of cis-dichlorodiammineplatinum (II) in squamous cell lung cancer","volume":"64","author":"Eagan","year":"1980","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.heares.2019.107878_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/14992027.2010.485595","article-title":"Long term hearing degeneration after platinum-based chemotherapy in childhood","volume":"49","author":"Einarsson","year":"2010","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.heares.2019.107878_bib21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3109\/14992027.2011.585667","article-title":"Severe difficulties with word recognition in noise after platinum chemotherapy in childhood and improvements with open0fitting hearing-aids","volume":"50","author":"Einarsson","year":"2011","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.heares.2019.107878_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.heares.2019.02.006","article-title":"An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity","volume":"375","author":"Fernandez","year":"2019","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.heares.2004.01.013","article-title":"Sex differences in distortion product otoacoustic emissions as a function of age in CBA mice","volume":"192","author":"Guimaraes","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2018.07.028","article-title":"Little evidence for a chronotolerance effect for impulse noise exposure in the C57BL\/6J mouse","volume":"684","author":"Harrison","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heares.2019.107878_bib25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/CAD.0000000000000395","article-title":"Ototoxicity of 12 mg\/kg cisplatin in the Fischer 344\/NHsd rat using multiple dosing strategies","volume":"27","author":"Harrison","year":"2016","journal-title":"Anti Canccer Drugs"},{"key":"10.1016\/j.heares.2019.107878_bib26","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J","article-title":"High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis","volume":"39","author":"Hayes","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.heares.2019.107878_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5955(03)00401-5","article-title":"Males lose hearing earlier in mouse models of late-onset age-related hearing loss; females lose hearing earlier in mouse models of early-onset hearing loss","volume":"190","author":"Henry","year":"2004","journal-title":"Hear. Res."},{"issue":"6","key":"10.1016\/j.heares.2019.107878_bib28","first-page":"731","article-title":"Temporal bone histopathology of cisplatin ototoxicity","volume":"16","author":"Hinojosa","year":"1995","journal-title":"Am. J. Otol."},{"key":"10.1016\/j.heares.2019.107878_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heares.2019.107878_bib30","article-title":"Increased burden of mitochondrial DNA deletions and point mutations in early-onset age-related hearing loss in mitochondrial mutator mice","volume":"110675","author":"Kim","year":"2019","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.heares.2019.107878_bib31","article-title":"The effects of age and sex on the detection of pure tones by adult CBA\/CaJ mice (Mus musculus)","volume":"24496","author":"Kobrina","year":"2019","journal-title":"J\u00a0Neurosci Res jnr"},{"key":"10.1016\/j.heares.2019.107878_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/019459988108900226","article-title":"Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum","volume":"89","author":"Komune","year":"1981","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heares.2019.107878_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0360-3016(96)00302-1","article-title":"Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment","volume":"36","author":"Kwong","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.heares.2019.107878_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2013.51.2038","article-title":"Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales\u2014a report from the children\u2019s oncology group","volume":"32","author":"Landier","year":"2014","journal-title":"J.\u00a0Clin. Orthod."},{"key":"10.1016\/j.heares.2019.107878_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cpt.603","article-title":"Drug-induced ototoxicity: mechanisms, Pharmacogenetics, and protective strategies","volume":"101","author":"Lanvers-Kaminsky","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.heares.2019.107878_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.12659\/MSM.899589","article-title":"Sex-related cochlear impairment in cigarette smokers","volume":"23","author":"Lisowska","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.heares.2019.107878_bib36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/00016489109138427","article-title":"Degeneration of the organ of Corti following intravenous administration of cisplatin","volume":"111","author":"Laurell","year":"1991","journal-title":"Acta Otolaryngol."},{"issue":"5","key":"10.1016\/j.heares.2019.107878_bib38","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3109\/00016489109138418","article-title":"Age-related loss of auditory sensitivity in two mouse genotypes","volume":"111","author":"Li","year":"1991","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.heares.2019.107878_bib39","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose","volume":"40","author":"Li","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.heares.2019.107878_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fncel.2019.00060","article-title":"Cellular differences in the cochlea of CBA and B6 mice may underlie their difference in susceptibility to hearing loss","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.heares.2019.107878_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13293-018-0171-0","article-title":"The impact of biological sex on the response to noise and otoprotective therapies against acoustic injury in mice","volume":"9","author":"Milon","year":"2018","journal-title":"Biol. Sex Differ."},{"issue":"1\u20132","key":"10.1016\/j.heares.2019.107878_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5955(00)00191-X","article-title":"Vulnerability to noise-induced hearing loss in \u2018middle-aged\u2019 and young aduly mice: a dose-response approach in CBA, C57BL, and BALB inbred strains","volume":"149","author":"Ohlemiller","year":"2000","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib43","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J.\u00a0Clin. Orthod."},{"key":"10.1016\/j.heares.2019.107878_bib44","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.ijporl.2014.08.039","article-title":"Hearing loss in a pediatric patient following cisplatin chemotherapy and subsequent exposure to excessive noise","volume":"78","author":"Peleva","year":"2014","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.heares.2019.107878_bib45","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1200\/JCO.2006.10.077","article-title":"Relationship between cisplatin administration and the development of ototoxicity","volume":"24","author":"Rademaker-Lakhai","year":"2006","journal-title":"J.\u00a0Clin. Orthod."},{"key":"10.1016\/j.heares.2019.107878_bib46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0773.1995.tb00167.x","article-title":"Mechanism of cisplatin ototoxicity: antioxidant system","volume":"76","author":"Ravi","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.heares.2019.107878_bib47","first-page":"19","article-title":"Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration","volume":"66","author":"Reddel","year":"1982","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.heares.2019.107878_bib48","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1172\/JCI71353","article-title":"Sound preconditioning therapy inhibits ototoxic hearing loss in mice","volume":"123","author":"Roy","year":"2013","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heares.2019.107878_bib49","first-page":"513","article-title":"Effect of protective agents against cisplatin ototoxicity","volume":"21","author":"Rybak","year":"2000","journal-title":"Am. J. Otol."},{"key":"10.1016\/j.heares.2019.107878_bib50","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5002434","volume":"72","author":"Rybak","year":"2007","journal-title":"Ototoxicity. Kidney Int."},{"key":"10.1016\/j.heares.2019.107878_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"226","author":"Rybak","year":"2007","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9610(78)90276-3","article-title":"Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum","volume":"136","author":"Sako","year":"1978","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.heares.2019.107878_bib53","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1200\/JCO.1998.16.2.702","article-title":"Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience","volume":"16","author":"Saxman","year":"1998","journal-title":"J.\u00a0Clin. Orthod."},{"key":"10.1016\/j.heares.2019.107878_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.oraloncology.2018.12.010","article-title":"Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients","volume":"89","author":"Teft","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.heares.2019.107878_bib55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00464252","article-title":"Analysis of hearing loss due to cis-diamminedichloroplatinum-II","volume":"239","author":"van Zeijl","year":"1984","journal-title":"Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.heares.2019.107878_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fnmol.2018.00469","article-title":"Mitochondrial calcium transporters mediate sensitivity to noise-induced losses of hair cells and cochlear synapses","volume":"11","author":"Wang","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.heares.2019.107878_bib57","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/MPH.0000000000001282","article-title":"Cisplatin-induced ototoxicity in children with solid tumor","volume":"41","author":"Wei","year":"2019","journal-title":"Journal of Pediatri Hematol\/Oncol"},{"key":"10.1016\/j.heares.2019.107878_bib58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7196\/SAMJ.7389","article-title":"High prevalence of cisplatin-induced ototoxicity in Cape Town, South Africa","volume":"104","author":"Whitehorn","year":"2014","journal-title":"S.\u00a0Afr. Med. J."},{"issue":"3","key":"10.1016\/j.heares.2019.107878_bib59","first-page":"359","article-title":"CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck","volume":"61","author":"Wittes","year":"1977","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.heares.2019.107878_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5955(01)00303-3","article-title":"Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague\u2013Dawley rat","volume":"158","author":"Wu","year":"2001","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.107878_bib61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.24138","article-title":"Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients","volume":"59","author":"Yancey","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.heares.2019.107878_bib62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0378-5955(99)00003-9","article-title":"Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses","volume":"130","author":"Zheng","year":"1999","journal-title":"Hear. Res."}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595519303958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595519303958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:52:42Z","timestamp":1759920762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595519303958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":62,"alternative-id":["S0378595519303958"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2019.107878","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cisplatin-induced threshold shift in the CBA\/CaJ, C57BL\/6J, BALB\/cJ mouse models of hearing loss","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2019.107878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107878"}}